fda glp-1 safety warning september 2025 Beyond the Headlines: Letters to Compounders GLP-1 medications like Ozempic, Wegovy

Competing with Novo Nordisk and Others Novo Nordisk remains a formidable competitor, having pioneered the GLP-1 weight-loss market

The FDA label for dosing of tirzepatide has not been provided yet but in the weight loss trial there was a similar dose escalation from 2.5 mg up to 15 mg by month 5

Since progesterone is crucial for protecting your endometrium (womb lining) from increased cancer risk, its important to ensure adequate absorption

Regulatory Mr Peps is not regulated by the MHRA because research peptides sold for in-vitro research use are not classed as medicines under the Human Medicines Regulations 2012